The Effect Of SGLT-2 Inhibitors On Improving Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.

Translation: The University of Toledo Journal of Medical Sciences Pub Date : 2023-12-15 DOI:10.46570/utjms.vol11-2023-933

W. Sayeh, Sudheer M. Dhoop, S. Chinnam, Rayna Patel, Azizullah Beran, Megan Karrick, A. Renno, Ali Nawras

引用次数: 0

Abstract

Discussion: Our meta-analysis demonstrated that the use of SGLT-2 inhibitors can be beneficial in patients with NAFLD in terms of lowering the level of liver enzymes (ALT and AST) and lowering the fibrosis index score (FIB-4).

查看原文本刊更多论文

SGLT-2 抑制剂对改善非酒精性脂肪肝的影响：系统回顾与元分析》。

讨论我们的荟萃分析表明，使用 SGLT-2 抑制剂可降低非酒精性脂肪肝患者的肝酶（谷丙转氨酶和谷草转氨酶）水平，并降低纤维化指数评分（FIB-4）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Translation: The University of Toledo Journal of Medical Sciences

自引率

0.00%

发文量